Basic Information
| RNALocate ID: | RLID:01002372 |
| RNA Symbol: | hsa-miR-532-5p |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-532-5p |
| RNA ID: | miRBase:MIMAT0002888 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22984580 |
| Tissue/Cell Line: | Cell line (HEK-293|HeLa) |
| Method: | Next-generation RNA sequencing |
| Description: | The differential association of miRNA to mitochondria of both HEK293 and HeLa has been summarized in Table S3. Data are collected from Table S3: Pattern of miRNAs associated with mitochondria of HEK293 and HeLa. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002369 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01002370 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002371 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002373 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002374 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11003146 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003147 | Exosome | Plasma | 23663360 |
| RLID:11003148 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11003149 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11003150 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11003151 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000157 | Exosome | Blood|B lymphoblastoid cells|Colon tissue|Endothelial cells|Kidney tissue|Seminal fluid|Tongue tissue | |
| RLID-D:11000503 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-532-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-58808 |
| MNDR | hsa-miR-532-5p | Oral squamous cell carcinoma | MNDR-E-MI-58809 |
| MNDR | hsa-miR-532-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-58810 |
| MNDR | hsa-miR-532-5p | Ovarian clear cell carcinoma | MNDR-E-MI-58811 |
| MNDR | hsa-miR-532-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-58812 |
| MNDR | hsa-miR-532-5p | Lymphoma | MNDR-E-MI-58813 |
| MNDR | hsa-miR-532-5p | Non-hodgkin lymphoma | MNDR-E-MI-58814 |
| MNDR | hsa-miR-532-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-58815 |
| MNDR | hsa-miR-532-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-58816 |
| MNDR | hsa-miR-532-5p | Niemann-pick disease type c | MNDR-E-MI-58817 |
| MNDR | hsa-miR-532-5p | Chronic lymphocytic leukemia | MNDR-E-MI-58818 |
| MNDR | hsa-miR-532-5p | Gastric cancer | MNDR-E-MI-58819 |
| MNDR | hsa-miR-532-5p | Alzheimer disease | MNDR-E-MI-58820 |
| MNDR | hsa-miR-532-5p | Intracranial aneurysm | MNDR-E-MI-58821 |
| MNDR | hsa-miR-532-5p | Dysautonomia familial | MNDR-E-MI-58822 |
| MNDR | hsa-miR-532-5p | Cardiovascular disease | MNDR-E-MI-58823 |
| MNDR | hsa-miR-532-5p | Lung cancer | MNDR-E-MI-58824 |
| MNDR | hsa-miR-532-5p | Parkinson disease | MNDR-E-MI-58825 |
| MNDR | hsa-miR-532-5p | Niemann-pick disease | MNDR-E-MI-58826 |
| MNDR | hsa-miR-532-5p | Basal-like breast cancer | MNDR-E-MI-58827 |
| MNDR | hsa-miR-532-5p | Pancreatic cancer | MNDR-E-MI-58828 |
| MNDR | hsa-miR-532-5p | Malignant melanoma | MNDR-E-MI-58829 |
| MNDR | hsa-miR-532-5p | Nephroblastoma | MNDR-E-MI-58830 |
| MNDR | hsa-miR-532-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-58831 |
| MNDR | hsa-miR-532-5p | Familial ovarian cancer | MNDR-E-MI-58832 |
| MNDR | hsa-miR-532-5p | Prostate adenocarcinoma | MNDR-E-MI-58833 |
| MNDR | hsa-miR-532-5p | Kidney cancer | MNDR-E-MI-58834 |
| MNDR | hsa-miR-532-5p | Glioblastoma | MNDR-E-MI-58835 |
| MNDR | hsa-miR-532-5p | Glioma | MNDR-E-MI-58836 |
| MNDR | hsa-miR-532-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-58837 |
| MNDR | hsa-miR-532-5p | Gastric adenocarcinoma | MNDR-E-MI-58838 |
| MNDR | hsa-miR-532-5p | Lung squamous cell carcinoma | MNDR-E-MI-58839 |
| MNDR | hsa-miR-532-5p | Lung adenocarcinoma | MNDR-E-MI-58840 |
| MNDR | hsa-miR-532-5p | Adrenocortical cancer | MNDR-E-MI-58841 |
| MNDR | hsa-miR-532-5p | Thyroid carcinoma | MNDR-E-MI-58842 |
| MNDR | hsa-miR-532-5p | Ovarian carcinoma | MNDR-E-MI-58843 |
| MNDR | hsa-miR-532-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-58844 |
| MNDR | hsa-miR-532-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-58845 |
| MNDR | hsa-miR-532-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-58846 |
| MNDR | hsa-miR-532-5p | Clear cell renal cell carcinoma | MNDR-E-MI-58847 |
| MNDR | hsa-miR-532-5p | Cholangiocarcinoma | MNDR-E-MI-58848 |
| MNDR | hsa-miR-532-5p | Liver cirrhosis | MNDR-E-MI-58849 |
| MNDR | hsa-miR-532-5p | Stomach carcinoma | MNDR-E-MI-58850 |
| MNDR | hsa-miR-532-5p | Early hepatocellular carcinoma | MNDR-E-MI-58851 |
| MNDR | hsa-miR-532-5p | Familiar ovarian carcinoma | MNDR-E-MI-58852 |
| MNDR | hsa-miR-532-5p | B-cell non-hodgkin lymphoma | MNDR-E-MI-58853 |
| MNDR | hsa-miR-532-5p | Rheumatoid arthritis | MNDR-E-MI-58854 |
| MNDR | hsa-miR-532-5p | Retinoblastoma | MNDR-E-MI-58855 |
| MNDR | hsa-miR-532-5p | Hodgkin lymphoma | MNDR-E-MI-58856 |
| MNDR | hsa-miR-532-5p | Neuromyelitis optica | MNDR-E-MI-58857 |
| MNDR | hsa-miR-532-5p | Colorectal cancer | MNDR-E-MI-58858 |
| MNDR | hsa-miR-532-5p | Nasopharynx carcinoma | MNDR-E-MI-58859 |
| MNDR | hsa-miR-532-5p | Multiple myeloma | MNDR-E-MI-58860 |
| MNDR | hsa-miR-532-5p | Nasopharyngeal cancer | MNDR-E-MI-58861 |
| MNDR | hsa-miR-532-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-58862 |
| MNDR | hsa-miR-532-5p | Stroke lacunar | MNDR-E-MI-58863 |
| MNDR | hsa-miR-532-5p | High grade dysplastic nodule | MNDR-E-MI-58864 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CXCL2 | Homo sapiens | RR00382479 |
TOP